glaxosmithkline pharma (MorganStanley) Stock Price Leveraged to Sales Growth - Retain EW

Date Rating Target Price Recommendation Price Broker house
22 Feb 2011 equalweight 2121 (from 1670) 2223 MorganStanley Report

No comments:

Post a Comment